Yiming Li

Yiming Li

Auto-generated profile, based on publicly available information

Yiming Li

AI for Life Sciences Lab, Tencent, Shenzhen, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2025 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
LLLinjing Liu
Linjing Liu
WLWei Li
Wei Li
FWFang Wang
Fang Wang
YLYiming Li
Yiming Li
LHLong-Kai Huang
Long-Kai Huang
JYJianhua Yao
Jianhua Yao

15 November 2026 in Nature Communications
Verified
Journal Article
Open access
JZJun Zhu
Jun Zhu
HLHongchao Li
Hongchao Li
YLYafang Li
Yafang Li
YLYiming Li
Yiming Li
GWGuibin Wang
Guibin Wang
CCCheng Chang
Cheng Chang

14 September 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZTZhenchao Tang
Zhenchao Tang
FWFang Wang
Fang Wang
FYFan Yang
Fan Yang
Jiangning SongJiangning Song
Jiangning Song
YLYiming Li
Yiming Li
JYJianhua Yao
Jianhua Yao
Single-cell sequencing offers profound insights into tumor complexity. However, reliably linking individual cellular profiles to overall sample-level phenotypes remains computationally challenging, particularly when cell-specific annotations are absent. This disconnect limits the technology’s utility in studying underlying tumor mechanisms. Here we show how scTransMIL, an artificial intelligence framework, bridges this gap. By conceptualizing a biological sample as a collection of individual cells, scTransMIL employs a transformer-based multi-instance learning approach to directly connect single-cell transcriptomic profiles with overarching sample-level labels. We demonstrate that scTransMIL accurately predicts sample-level cancer phenotypes, including the tissue-of-origin for metastatic tumors. At cellular resolution, it robustly identifies tumor-associated cell populations and maps biological progression trajectories using only minimal sample-level annotations. Furthermore, the model’s attention mechanisms facilitate full-transcriptome biomarker discovery. By systematically integrating molecular and cellular scales with broader phenotypic states, our approach provides a computational tool to dissect tumor heterogeneity and advance fundamental cancer biology.